• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

First ‘pathoconnectome’ could point toward new treatments for neurodegenerative diseases

Bioengineer by Bioengineer
September 29, 2020
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The pathoconnectome can be used to identify potential new treatments for neurodegenerative diseases, including epilepsy and Alzheimer’s, by showing how they rewire neural systems

IMAGE

Credit: John A. Moran Eye Center

SALT LAKE CITY–Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons.

Moran’s Marclab for Connectomics was the first to complete a map of the circuitry of the retina, or connectome, in 2011. Now, the National Institutes of Health (NIH)-funded lab has produced the first pathoconnectome, showing how eye disease alters retinal circuitry.

The implications of the published research, A pathoconnectome of early neurodegeneration: Network changes in retinal degeneration, extend far beyond eye diseases. The eye holds lessons applicable to a host of neurodegenerative diseases including Alzheimer’s, Parkinson’s, epilepsy, and Lou Gehrig’s disease.

“The components of neurodegeneration we see in the eye seem to mimic those we see in the brain,” explained the paper’s lead author, Moran’s Rebecca L. Pfeiffer, PhD. “So this pathoconnectome is allowing us to learn fundamental rules of how neurodegenerative diseases alter neural networks in general. The ultimate goal is to identify how we might develop new therapies based on preventing or interfering with the network rewiring prompted by disease.”

The Marclab developed the pathoconnectome from a model of early-stage retinitis pigmentosa (RP), an inherited retinal disease that can lead to blindness. The immense data set compiled to construct the pathoconnectome has taken years to assemble and is open for use by other scientists. The Marclab is working on a second and third pathoconnectome that will show how the retina rewires itself in later stages of RP.

###

In addition to Pfeiffer, 12 other Marclab researchers are authors on the publication: James R. Anderson, PhD; Jeebika Dahal; Jessica C. Garcia; Jia-Hui Yang; Crystal L. Sigulinsky PhD; Kevin Rapp; Daniel P. Emrich; Carl B. Watt, PhD; Hope AB Johnstun; Alexis R. Houser; Robert E. Marc, PhD; and lab director Bryan W. Jones, PhD.

The Marclab constructed the pathoconnectome by studying 946 tissue sections with two transmission electron microscopes, which work nonstop nearly every day of the year to produce an unprecedented amount of data to understand retinal circuitry. In 2018, the Lawrence T. and Janet T. Dee Foundation generously funded the lab’s second transmission electron microscope. The first was provided by Moran donor Martha Ann Dumke Healy.

Watch a video to learn more about the pathoconnectome.

Media Contact
Elizabeth Neff
[email protected]

Original Source

https://healthcare.utah.edu/moran/news/2020/09/pathoconnectome.php

Related Journal Article

http://dx.doi.org/10.1016/j.exer.2020.108196

Tags: BiologyCell BiologyMedicine/HealthneurobiologyOphthalmology
Share13Tweet8Share2ShareShareShare2

Related Posts

Barriers and Boosters of Seniors’ Physical Activity in Karachi

February 7, 2026

Evaluating Pediatric Emergency Care Quality in Ethiopia

February 7, 2026

TPMT Expression Predictions Linked to Azathioprine Side Effects

February 7, 2026

Improving Dementia Care with Enhanced Activity Kits

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Barriers and Boosters of Seniors’ Physical Activity in Karachi

Evaluating Pediatric Emergency Care Quality in Ethiopia

TPMT Expression Predictions Linked to Azathioprine Side Effects

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.